Increasing demand for precise diagnosis methods is one of the significant factors influencing the market growth.
Increasing demand for precise diagnosis methods is one of the significant factors influencing the market growth.
The nuclear medicine imaging market size is estimated to reach USD 6,047.2 Million from USD 4,249.4 Million in 2020, delivering a CAGR of 4.6% through 2027. The market growth is driven by a plethora of factors, including the growing prevalence of cancer & cardiovascular diseases, investments for the modernization of diagnostics imaging centers, the introduction of new & advanced products, along with the development of new radiotracers.
Favorable reimbursement scenario for positron emission tomography (PET scans) in many countries, along with the high accuracy of nuclear imaging, is propelling nuclear medicine imaging market growth through 2027.
Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2415
In January 2019, Kansen voor West organization and the EFRO (European Fund for Regional Development) had funded USD 7.67 million to FIELD-LAB for developing new nuclear medicines for cancer treatment. Such government initiatives and funding for the development of new techniques will further propel nuclear medicine market share over the forecast period.
Further key findings from the report suggest
- Based on type, the positron emission tomography (PET) systems segment is anticipated to witness the fastest growth rate of 5.1% through 2027.
- The single-photon emission computed tomography systems accounted for a major chunk of the global nuclear medicine market share in 2019 and is forecast to register a CAGR of 4.4% through 2027. SPECT imaging is experiencing high demand as it offers complementary functional and anatomic image data to improve the depth of information, which is less expensive than PET and widely available.
- On the basis of application, the oncology segment dominated the nuclear medicine market revenue share in 2019 and is expected to witness a CAGR of 4.1% over the projected timeframe.
- On the basis of end-use, the research institute segment is estimated to witness a notable growth rate of 5.6% through 2027.
- In 2019, the hospitals segment accounted for the largest market share in 2019 and is estimated to exhibit a CAGR of 4.2% during the analysis period. The key factors responsible for segmental growth are the availability of well-resourced diagnostic rooms, the existence of highly skilled healthcare professionals, improved health coverage for hospital-based healthcare services from several private and group insurance plans, and substantial funds for investing in new equipment and technologies.
- In the regional landscape, the Asia Pacific region is estimated to register a growth rate of 5.9% through 2027 on account of the high demand for nuclear medicine in emerging economies, including India and China, with rising healthcare standards in these countries.
- In 2019, Europe accounted for the second-largest share of the nuclear medicine market and is anticipated to showcase a CAGR of 4.4% through 2027 on account of the presence of leading market players in the region.
- North America dominated the market in 2018 and is likely to observe a growth rate of 4.4% in the forecast period. The market dominance of North America is owing to rapid technological advancements, such as the growing incidence of target diseases, the development of molecular imaging, and the launch of new radiopharmaceuticals for diagnosis, among others.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2415
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
GE Healthcare, Lantheus Medical Imaging, Curium, Nordion, Novartis, Bayer, Eczacibasi-Monrol Nuclear Products, Cardinal Health, Bracco Imaging SPA, and Siemens Healthineers, among others.
Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/nuclear-medicine-imaging-market
Nuclear Medicine Imaging Market Segmentation:
Type Outlook (Revenue, USD Million; 2018-2028)
- Single-Photon Emission Computed Tomography (SPECT) Systems
- Positron Emission Tomography (PET) Systems
Application Outlook (Revenue, USD Million; 2018-2028)
- Oncology
- Cardiology
- Neurology
- Thyroid
- Others
End-User Outlook (Revenue, USD Million; 2018-2028)
- Hospitals
- Diagnostic Centers
- Research Institutes
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2415
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore More Industry Research by Reports and Data:
Intravascular Ultrasound (IVUS) Market Size, Share And Industry Analysis By Modality (Virtual Histology IVUS, IMAP, Integrated Backscatter IVUS), By Products (Accessories, Consoles), By End Users (Hospitals, Diagnostic Centers, Academic And Research Institutes) And Region, Segment Forecasts To 2028 - Download PDF Brochure
Spinal Devices Market Size, Share And Industry Analysis By Device Type (Fusion Devices, Non-Fusion Devices, Spinal Electrical Simulation Devices), By Disease Type (Degenerative Disc Disease, Traumas and Fractures, Complex Deformity, Others), By Surgery Type (Open Surgery, Minimally Invasive Surgery), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers) And Region, Segment Forecasts To 2028 - Download PDF Brochure
Endotoxin Testing Market Analysis By Test Methods (Gel-Clot Test, Turbidimetry Test Method), By Application (Biopharmaceutical Raw Materials, Parenteral Medicines), By End Use (Biopharmaceutical and Pharmaceutical Companies), And Region, Forecasts To 2028 - Download PDF Brochure
T-Cell Therapy Market By Modality (Research, Commercialized), By Therapy, (CAR T-cell Therapy, T-cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based), By Indication (Hematologic Malignancies, Solid Tumors), and By Region, Forecast to 2028 - Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos